Nation on strong momentum of IPOs, demonstrating resilience to global headwinds HANOI, Vietnam, Oct. 30, 2023 /PRNewswire/ -- Vietnam Venture Summit 2023, hosted by Vietnam's Ministry of Planning...

Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid...

ImmPACT Bio USA, Inc. ("ImmPACT BIO"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR) T-cell therapies for treating cancer and autoimmune...

Opus IVS™, offering an integrated platform of OE and multi-brand diagnostics, remote programming, and calibration solutions, anchored by expert technicians and cutting-edge patented technology,...

New preclinical data presented at CTAD demonstrates exciting potential for a new drug approach for Alzheimer's disease, reducing brain tau pathology by ~70% CAMBRIDGE, Mass., Oct. 30, 2023...